Understanding the causes of hypertrophic cardiomyopathy in children and adolescents
Mechanical and Metabolic Pathways Underlying MYBPC3 Hypertrophic Cardiomyopathy
This study is looking at how changes in a specific gene related to hypertrophic cardiomyopathy (HCM) affect the heart, using special lab models to better understand the disease in young people, with the hope of finding new treatments to help those with HCM live healthier lives.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11110171 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms behind hypertrophic cardiomyopathy (HCM), particularly focusing on the MYBPC3 gene, which is often mutated in affected individuals. The principal investigator, Dr. Joshua Meisner, is developing innovative models using induced pluripotent stem cells and mice to mimic the disease as it occurs in young patients. By studying these models, the research aims to uncover how mechanical and energetic stresses contribute to the progression of HCM, which can lead to serious health issues like heart failure. The ultimate goal is to identify potential therapeutic approaches that could improve outcomes for affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are children and adolescents diagnosed with hypertrophic cardiomyopathy, particularly those with MYBPC3 gene mutations.
Not a fit: Patients with hypertrophic cardiomyopathy not related to MYBPC3 mutations or those with other unrelated cardiac conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve the health and quality of life for children and adolescents with hypertrophic cardiomyopathy.
How similar studies have performed: Previous research has shown promise in using stem cell models to study cardiac diseases, indicating that this approach could yield valuable insights into hypertrophic cardiomyopathy.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Meisner, Joshua K — University of Michigan at Ann Arbor
- Study coordinator: Meisner, Joshua K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.